These findings suggest that GPER mediates the anticancer or pro-oncogenic effects of E2 in ERs-negative CRC, with the former occurring under normoxic conditions and the latter under hypoxic conditions (Fig. 4). This evidence concerns the gene GPER1 and colorectal carcinoma.